Multiple Sclerosis Clinical Trial
A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis
Summary
This is a US-based, observational cross-sectional study with primary data collection via questionnaires directly administered to patients with MS receiving KESIMPTA and care partners of patients with MS (formal or informal)receiving KESIMPTA.
Full Description
The study aimed to enroll ninety-four (94) patients/care partners. The time period for enrollment was dependent on the uptake of KESIMPTA in the real-world.
Data collected for the study was obtained directly from the patient/care partner within the web-based database: De-identified data was stored on a secure server and transferred for analysis. Responses from the patient and care partner surveys were pooled for analysis of study endpoints.
Eligibility Criteria
Patients with MS Inclusion Criteria:
Adult aged eighteen (18) years of age or over at the time of the survey
Prescribed KESIMPTA within the prior 12 months and currently self-administering treatment using the Sensoready® pen
MS diagnosis based on 2017 McDonald criteria
Care Partner Inclusion Criteria:
Adult aged eighteen (18) years of age or over
Formal or informal care partner of patient with MS prescribed KESIMPTA within the prior 12 months
Is currently administering KESIMPTA using the Sensoready® pen on their patient's behalf
Patients with MS Exclusion Criteria:
Previously used injection as a part of inclusion in any ofatumumab (OMB) randomized clinical trial
Active Hepatitis B virus (HBV)
Cognitive impairment that would impact their ability to participate in a survey study
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
East Hanover New Jersey, 07936, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.